Brainaurora Medical Technology Ltd. engages in research and development of medical-grade cognitive impairment digital therapeutics (DTx) products. It offers the advanced artificial intelligence technologies and products for the treatment of cognitive impairment diseases. The company was founded on April 25, 2023 and is headquartered in Shaoxing, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company